BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36296442)

  • 1. Nardoguaianone L Isolated from
    Zheng YD; Ma LM; Lu JJ; Chai T; Naghavi MR; Ma JY; Sang CY; Yang JL
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Anti-Tumor Activity of Nardoguaianone L Isolated from
    Sang CY; Zheng YD; Ma LM; Wang K; Wang CB; Chai T; Eshbakova KA; Yang JL
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
    Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terpenoids from Nardostachys jatamansi and their cytotoxic activity against human pancreatic cancer cell lines.
    Ma LM; Wang K; Meng XH; Zheng YD; Wang CB; Chai T; Naghavi MR; Sang CY; Yang JL
    Phytochemistry; 2022 Aug; 200():113228. PubMed ID: 35561851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
    Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z
    Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling.
    Jin H; Zhao Y; Yang J; Zhang X; Ma S
    Oncol Lett; 2018 Nov; 16(5):6742-6748. PubMed ID: 30405817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism.
    Fujiwara-Tani R; Sasaki T; Takagi T; Mori S; Kishi S; Nishiguchi Y; Ohmori H; Fujii K; Kuniyasu H
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.
    Donadelli M; Costanzo C; Beghelli S; Scupoli MT; Dandrea M; Bonora A; Piacentini P; Budillon A; Caraglia M; Scarpa A; Palmieri M
    Biochim Biophys Acta; 2007 Jul; 1773(7):1095-106. PubMed ID: 17555830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway.
    Wang J; Zhang Y; Liu X; Wang J; Li B; Liu Y; Wang J
    Int J Mol Med; 2019 Sep; 44(3):1026-1038. PubMed ID: 31524219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine sensitizes pancreatic cancer cells to the CTLs antitumor response induced by BCG-stimulated dendritic cells via a Fas-dependent pathway.
    Pei Q; Pan J; Ding X; Wang J; Zou X; Lv Y
    Pancreatology; 2015; 15(3):233-9. PubMed ID: 25937078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters.
    Qiu F; Chen J; Cao J; Diao F; Huang P
    Oncol Rep; 2020 Sep; 44(3):1158-1168. PubMed ID: 32705228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
    Yang Y; Tian W; Yang L; Zhang Q; Zhu M; Liu Y; Li J; Yang L; Liu J; Shen Y; Qi Z
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):93-103. PubMed ID: 32897433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
    Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
    Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer.
    Li L; Zhao SL; Yue GGL; Wong TP; Pu JX; Sun HD; Fung KP; Leung PC; Han QB; Lau CBS; Leung PS
    Phytomedicine; 2018 May; 44():56-64. PubMed ID: 29895493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of HSP27 on Gemcitabine-Resistant Pancreatic Cancer Cell Line Through Snail.
    Zhang S; Zhang XQ; Huang SL; Chen M; Shen SS; Ding XW; Lv Y; Zou XP
    Pancreas; 2015 Oct; 44(7):1121-9. PubMed ID: 26348464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
    Zou J; Su H; Zou C; Liang X; Fei Z
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.
    Donadelli M; Dando I; Zaniboni T; Costanzo C; Dalla Pozza E; Scupoli MT; Scarpa A; Zappavigna S; Marra M; Abbruzzese A; Bifulco M; Caraglia M; Palmieri M
    Cell Death Dis; 2011 Apr; 2(4):e152. PubMed ID: 21525939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
    Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.